Michael Heinsch

Clinical, morphological, cytogenetic, and prognostic features of patients with myelodysplastic syndromes and del(5q) including band q31

Aristoteles Giagounidis, Ulrich Germing, Sabine Haase et al. · Leukemia · 2003 · 209 citations

Life Sciences, Genetics, Hematology +16

Prognosis of patients with del(5q) MDS and complex karyotype and the possible role of lenalidomide in this patient subgroup

Aristoteles Giagounidis, Ulrich Germing, Corinna Strupp et al. · Annals of Hematology · 2005 · 75 citations

Medicine, Hematology, Oncology +11

Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 Trial

K. Elias, Uta Bertsch, Ema Požek et al. · Journal of Clinical Oncology · 2024 · 62 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

C-X-C Motif Chemokine Receptor 4–Targeted Radioligand Therapy in Patients with Advanced T-Cell Lymphoma

Andreas K. Buck, Götz Ulrich Grigoleit, Sabrina Kraus et al. · Journal of Nuclear Medicine · 2022 · 48 citations · Full text

Medicine, Hematology, Oncology +17

Acute basophilic leukemia

Aristoteles Giagounidis, Barbara Hildebrandt, Michael Heinsch et al. · European Journal Of Haematology · 2001 · 34 citations · Full text

Medicine, Hematology, Oncology +17